An Improved P(V) Thio-Oligonucleotide Synthesis Platform.

Area of Science:

• Chemical Synthesis
• Oligonucleotide Chemistry
• Medicinal Chemistry

Background:

• Phosphorothioate oligonucleotides are crucial in therapeutics.
• Current synthesis methods for stereopure phosphorothioates are complex and costly.
• Widespread adoption of this technology is hindered by these challenges.

Purpose of the Study:

• To simplify the adoption of P(V)-based stereopure, phosphorothioate-containing oligonucleotide synthesis.
• To reduce the barrier to entry for researchers and manufacturers.
• To enable broader therapeutic applications of these molecules.

Main Methods:

• Introduction of a novel, cost-effective phosphorus-sulfur incorporation reagent (Ψ).
• Development of a robust and efficient linker system for solid-phase synthesis.
• Systematic evaluation and optimization of common nucleobase protecting groups for this specific application.

Main Results:

• The new reagent (Ψ) offers a more economical route for sulfur incorporation.
• The developed linker system ensures high yields and purity.
• Optimized protecting groups minimize side reactions and improve overall efficiency.

Conclusions:

• The reported advances significantly lower the technical and economic barriers to synthesizing stereopure phosphorothioate oligonucleotides.
• This simplification facilitates wider use of this important class of molecules in research and drug development.
• The optimized methodology paves the way for scalable and cost-effective production.